Drugs for Keratoconus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 147)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Ranibizumab |
Approved |
Phase 4 |
|
347396-82-1 |
459903
|
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
ranibizumab
|
Ranibizumab
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
Ranibizumab (USAN/INN)
rhuFab V2
|
|
2 |
|
Flavin Mononucleotide |
Approved, Investigational |
Phase 4,Phase 2,Phase 3,Not Applicable |
|
146-17-8 |
643976
|
Synonyms:
5'-Monophosphate, riboflavin
5'-Phosphate, riboflavin
Flanin
Flavin mononucleotide disodium salt
Flavin mononucleotide monosodium salt
Flavin mononucleotide monosodium salt, dihydrate
Flavin mononucleotide sodium salt
Flavine mononucleotide
Flavol
FMN
Mononucleotide, flavin
Mononucleotide, riboflavin
Phosphate, sodium riboflavin
Riboflavin
Riboflavin 5' monophosphate
Riboflavin 5' phosphate
riboflavin 5'-(dihydrogen phosphate)
Riboflavin 5'-(dihydrogen phosphate)
Riboflavin 5'-(dihydrogen phosphoric acid)
riboflavin 5'-monophosphate
Riboflavin 5'-monophosphate
Riboflavin 5'-monophosphoric acid
riboflavin 5'-phosphate
|
Riboflavin 5'-phosphate
Riboflavin 5'-phosphoric acid
Riboflavin mononucleotide
Riboflavin monophosphate
Riboflavin monophosphoric acid
Riboflavin phosphate
Riboflavin phosphate, sodium
Riboflavin-5-phosphate
Riboflavin-5'-phosphate na
Riboflavin-5-phosphoric acid
Riboflavine 5'-monophosphate
Riboflavine 5'-phosphate
riboflavine dihydrogen phosphate
Riboflavine dihydrogen phosphate
Riboflavine dihydrogen phosphoric acid
Riboflavine monophosphate
Riboflavine phosphate
Riboflavine-5'-phosphate
Sodium riboflavin phosphate
Vitamin B2 (riboflavin-5-phosphate)
Vitamin b2 phosphate
Vitamin B2 phosphate
|
|
3 |
|
Ketorolac |
Approved |
Phase 4 |
|
66635-83-4, 74103-06-3 |
3826
|
Synonyms:
(.+/-.)-2,3-Dihydro-5-benzoyl-1H-pyrrolizine-1-carboxylic acid
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-isomer
(+-)-Ketorolac
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro
5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
5-Benzoyl-1,2-dihydro-3H-pyrrolo(1,2a)pyrrole-1-carboxylic acid
5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
66635-83-4
74103-06-3
AB00053682
AC1L1GSW
AC-545
BRD-A40639672-234-05-7
C07062
CHEBI:105080
CHEMBL469
CID3826
D020910
D08104
DB00465
I14-2832
Ketoralac
|
ketorolac
Ketorolac
Kétorolac
Ketorolac (INN)
Ketorolac [INN:BAN]
Ketorolac tromethamine
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
LS-139094
Macril
MolPort-005-933-093
NCGC00185990-01
rac-Ketorolac
RS 37619
RS-37619
SBB067312
STL018674
Toradol
Toradol (TN)
UNII-YZI5105V0L
|
|
4 |
|
Gabapentin |
Approved, Investigational |
Phase 4 |
|
60142-96-3 |
3446
|
Synonyms:
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
1-(Aminomethyl)cyclohexaneacetate
1-(Aminomethyl)cyclohexaneacetic acid
1-(Aminomethyl)-cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
Aclonium
AKOS000280865
apo-Gabapentin
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
Convalis
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G0318
G-154
G154_SIGMA
Gabapen
gabapentin
Gabapentin (JAN/USAN/INN)
gabapentin (Neurontin)
Gabapentin [USAN:INN:BAN]
Gabapentin GR
Gabapentin hexal
Gabapentin Hexal
Gabapentin stada
Gabapentin Stada
gabapentina
Gabapentina
Gabapentine
Gabapentine [INN-French]
gabapentinium
Gabapentino
|
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentin-ratiopharm
Gabapentinum
Gabapentinum [INN-Latin]
Gabapetin
GBN
Go 3450
GOE 2450
Goe-3450
Hexal brand of gabapentin
HMS1570N03
HMS2089J03
HSDB 7364
I06-0677
L000733
Lopac0_000582
Lopac-G-154
LS-7194
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
Neurontin
Neurontin (TN)
novo-Gabapentin
Novo-Gabapentin
novo-Gabapentine
Novopharm brand of gabapentin
NSC742194
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
PMS-Gabapentin
Prestwick_151
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
ratiopharm brand of gabapentin
S2133_Selleck
Serada
SMR000058311
SPBio_002822
Stadapharm brand of gabapentin
STK598009
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
|
|
5 |
|
Riboflavin |
Approved, Investigational, Nutraceutical, Vet_approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
83-88-5 |
493570
|
Synonyms:
(-)-Riboflavin
1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol
1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol
6,7-Dimethyl-9-D-ribitylisoalloxazine
6,7-Dimethyl-9-ribitylisoalloxazine
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-benzo[g]pteridine-2,4(3H,10H)-dione
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine
7,8-Dimethyl-10-ribitylisoalloxazine
Beflavin
Beflavine
benzo[g]Pteridine riboflavin deriv.
e 101
e101
Flavaxin
Flavin BB
Flaxain
FOOD Yellow 15
Hyre
Lactobene
Lactoflavin
|
Lactoflavine
Ribipca
Ribocrisina
Riboderm
Riboflavina
Riboflavine
RIBOFLAVINE
Riboflavinum
Ribosyn
Ribotone
Ribovel
Russupteridine yellow III
San yellow b
Vitaflavine
Vitamin b 2
Vitamin b2
Vitamin B2
Vitamin Bi
Vitamin g
Vitamin G
Vitasan b2
|
|
6 |
|
Folic Acid |
Approved, Nutraceutical, Vet_approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
59-30-3 |
6037
|
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
|
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
7 |
|
Rhein |
Experimental |
Phase 4 |
|
478-43-3 |
10168
|
Synonyms:
1,8-Dihydroxy-3-carboxyl anthraquinone
1,8-Dihydroxy-3-carboxyl-9,10-anthraquinone
1,8-Dihydroxyanthraquinone-3-carboxylic acid
4, 5-Dihydroxyanthraquinone-2-carboxylic acid
4,5-Dihydroxy-2-anthraquinonecarboxylic acid
4,5-Dihydroxyanthraquinone-2-carboxylic acid
4,5-DiOH-anthraquinone-2-COOH
9,10-dihydro-4,5-Dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, 9ci
|
9,10-dihydro-4,5-Dihydroxy-9,10-dioxo-2-anthroic acid
Cassic acid
Chrysazin-3-carboxylic acid
Dipropionyl rhein
Monorhein
Rhein (1,8-dihydroxy-3-carboxyl anthraquinone)
Rhubarb yellow
|
|
8 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
9 |
|
Angiogenesis Modulating Agents |
|
Phase 4 |
|
|
|
10 |
|
Angiogenesis Inhibitors |
|
Phase 4 |
|
|
|
11 |
|
Ophthalmic Solutions |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
12 |
|
Central Nervous System Depressants |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
13 |
|
Peripheral Nervous System Agents |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
14 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
15 |
|
Anti-Inflammatory Agents |
|
Phase 4,Phase 2 |
|
|
|
16 |
|
Vitamin B2 |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
17 |
|
Pharmaceutical Solutions |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
18 |
|
Vitamin B Complex |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
19 |
|
Photosensitizing Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
20 |
|
Micronutrients |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
21 |
|
Vitamins |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
22 |
|
Vitamin B9 |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
23 |
|
Folate |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
24 |
|
Trace Elements |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
25 |
|
Dermatologic Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
26 |
|
Ketorolac Tromethamine |
|
Phase 4 |
|
|
|
27 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
28 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
29 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
30 |
|
Analgesics |
|
Phase 4 |
|
|
|
31 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
32 |
|
Anticonvulsants |
|
Phase 4 |
|
|
|
33 |
|
Anti-Anxiety Agents |
|
Phase 4 |
|
|
|
34 |
|
Antiparkinson Agents |
|
Phase 4 |
|
|
|
35 |
|
calcium channel blockers |
|
Phase 4 |
|
|
|
36 |
|
Excitatory Amino Acid Antagonists |
|
Phase 4 |
|
|
|
37 |
|
Tranquilizing Agents |
|
Phase 4 |
|
|
|
38 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
39 |
|
Excitatory Amino Acids |
|
Phase 4 |
|
|
|
40 |
|
Antimanic Agents |
|
Phase 4 |
|
|
|
41 |
|
Neurotransmitter Agents |
|
Phase 4,Not Applicable |
|
|
|
42 |
|
Lidocaine |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
137-58-6 |
3676
|
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(diethylamino)-2',6'-Acetoxylidide
2-(Diethylamino)-2',6'-acetoxylidide
2-(diethylamino)-N-(2,6-Dimethylphenyl)acetamide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
a-diethylamino-2,6-Dimethylacetanilide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
AKOS001026768
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alphacaine
alpha-diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-Dimethylacetanilide
alpha-Diethylamino-2,6-dimethylacetanilide
Anestacon
Anestacon Jelly
ARONIS23855
Astrazeneca brand OF lidocaine
BIDD:GT0342
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
C07073
C14H22N2O
Cappicaine
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
Cito optadren
CPD000058189
Cuivasil
D00358
Dalcaine
DB00281
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jenapharm brand OF lidocanine hydrochloride
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L0156
L1026_SIGMA
L7757_SIGMA
Lanabiotic
L-Caine
|
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
lidocaine
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine [USAN:INN:JAN]
Lidocaine carbonate
Lidocaine Carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine Hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
Lidocaine Monohydrochloride
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
LIDOPEN
Lignocaine
Lignocainum
Lingocaine
Lopac0_000669
Lopac-L-5647
LQZ
LS-805
Maricaine
Maybridge1_002571
MLS000069724
MLS000758263
MLS001074177
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
nchembio.65-comp16
NINDS_000174
Norwood Sunburn Spray
Novocol brand OF lidocaine hydrochloride
NSC 40030
NSC40030
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
Solarcaine aloe extra burn relief cream
Solcain
SPBio_001525
SPBio_002100
Spectrum_001118
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
STK552033
Strathmann brand OF lidocaine hydrochloride
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
α-diethylamino-2,6-dimethylacetanilide
|
|
43 |
|
Dipivefrin |
Approved |
Phase 3,Not Applicable |
|
52365-63-6 |
3105
|
Synonyms:
( -)-2,2-Dimethylpropansaeure-4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylenester
( -)-4-(1-Hydroxy-2-methylaminoethyl)-o-phenylendipivalat
(+-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol 3,4-dipivalate
(+-)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalic acid
(RS)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate
1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol
1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol
2,2-Dimethylpropanoic acid 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate)
4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalic acid
52365-63-6
AB00514686
AC1L1F6K
Adrenaline dipivalate
AKOS003662293
AKPro
Alcon brand OF dipivefrin hydrochloride
Allergan brand OF dipivefrin hydrochloride
apo-Dipivefrin
Apotex brand OF dipivefrin hydrochloride
BPBio1_000688
BRD-A47494775-003-03-0
BSPBio_000624
C06963
C19H29NO5
CHEBI:4646
CID3105
D Epifrin
D02349
DB00449
Diopine
Dipivaloylepinephrine
dipivalyl epinephrine
Dipivalyl epinephrine
Dipivalyl Epinephrine
dipivefrin
Dipivefrin
Dipivefrin (USAN)
Dipivefrin [USAN]
|
Dipivefrin acetate, (+-)-isomer
Dipivefrin citrate (1:1), (+-)-isomer
Dipivefrin HCL
Dipivefrin hydrochloride
Dipivefrin hydrochloride, (+-)-isomer
Dipivefrin monophosphate, (+-)-isomer
Dipivefrin monosulfate, (+-)-isomer
Dipivefrin nitrate, (+-)-isomer
Dipivefrin perchlorate
Dipivefrin propanoate, (+-)-isomer
Dipivefrin tartrate (1:1), (+-)-(R-(r*,r*))-isomer
Dipivefrin tartrate (1:1), (R)-(R-(r*,r*))-isomer
Dipivefrin, (R)-isomer
Dipivefrina
Dipivefrina [INN-Spanish]
Dipivefrine
Dipivéfrine
Dipivefrine (INN)
Dipivefrinum
Dipivefrinum [INN-Latin]
Dipoquin
Glaucothil
Glaudrops
Ioquin brand OF dipivefrin hydrochloride
K 30081
L000915
LS-121419
NCGC00179499-01
nchembio747-comp3
Ophtho-Dipivefrin
Pharm-allergan brand OF dipivefrin hydrochloride
Pharmascience brand OF dipivefrin hydrochloride
PMS-Dipivefrin
Prestwick0_000632
Prestwick1_000632
Prestwick2_000632
Prestwick3_000632
Pro-Epinephrine
Propine
Propine C Cap B.I.D.
ratio-Dipivefrin
Ratiopharm brand OF dipivefrin hydrochloride
SPBio_002843
UNII-8Q1PVL543G
|
|
44 |
|
Benzocaine |
Approved, Investigational |
Phase 3 |
|
94-09-7, 1994-09-7 |
2337
|
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl Aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
|
Ethyl PABA
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-Aminobenzoate
Ethyl P-aminobenzoate
Ethyl P-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-Aminophenylcarboxylate
Ethyl P-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny P-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
P-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
P-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
P-Carbethoxyaniline
p-Ethoxycarboxylic aniline
p-Ethoxycarboxylic Aniline
P-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
45 |
|
tannic acid |
Approved |
Phase 3 |
|
|
|
46 |
|
Anesthetics |
|
Phase 3,Phase 2,Not Applicable |
|
|
|
47 |
|
Anti-Bacterial Agents |
|
Phase 3,Phase 1,Not Applicable |
|
|
|
48 |
|
Antibiotics, Antitubercular |
|
Phase 3,Phase 1,Not Applicable |
|
|
|
49 |
|
Diuretics, Potassium Sparing |
|
Phase 2, Phase 3 |
|
|
|
50 |
|
Anesthetics, Local |
|
Phase 2, Phase 3,Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 186)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis |
Unknown status |
NCT01669447
|
Phase 4 |
|
2 |
Effect of CACICOL20 on Corneal Epithelial Healing After Cross-linking in Patients With Keratoconus |
Completed |
NCT02119039
|
Phase 4 |
|
3 |
Pain Management in Corneal Collagen Crosslinking for Keratoconus |
Completed |
NCT02867176
|
Phase 4 |
Gabapentin;Ketorolac |
4 |
Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Riboflavin |
Completed |
NCT01485211
|
Phase 4 |
cross-linking with hypo-osmolar riboflavin |
5 |
Intrastromal Corneal Ring for High Astigmatism on Postkeratoplasty |
Completed |
NCT01018797
|
Phase 4 |
|
6 |
Cross-Linking ACcéléré Iontophorèse Confocal kératocONE |
Recruiting |
NCT03429569
|
Phase 4 |
Cross linking |
7 |
Epi-On Corneal Crosslinking for Keratoconus |
Enrolling by invitation |
NCT03245853
|
Phase 4 |
Riboflavin 5'-Phosphate |
8 |
Non-inferiority Trial of Iontophoretic Corneal Collagen Crosslinking (CXL) Compared to Standard Corneal Collagen Crosslinking in Progressive Keratoconus. |
Unknown status |
NCT01868620
|
Phase 3 |
|
9 |
Refractive Treatment of Early Keratoconus |
Unknown status |
NCT02613780
|
Phase 3 |
|
10 |
Safety and Effectiveness of Collagen Cross Linking in Progressive Mild and Moderate Keratoconus |
Unknown status |
NCT00815256
|
Phase 3 |
|
11 |
Treatment of Keratoconus Using Collagen Cross-Linking |
Unknown status |
NCT00841386
|
Phase 2, Phase 3 |
Riboflavin-5-phosphate;Sham cross-linking |
12 |
Evaluating the Safety and Efficacy of the KXL System for Corneal Collagen Cross-Linking in Eyes Having Keratoconus |
Unknown status |
NCT02638376
|
Phase 3 |
|
13 |
Comparison of Penetrating Keratoplasty and Deep Lamellar Keratoplasty With the Big Bubble Technique for Keratoconus |
Unknown status |
NCT00371202
|
Phase 3 |
|
14 |
Evaluating Collagen Cross-Linking (CCL) Treatment in Norway |
Unknown status |
NCT00435799
|
Phase 2, Phase 3 |
Riboflavin/dextran eyedrops |
15 |
Corneal Cross-Linking Comparing Variables |
Unknown status |
NCT02095730
|
Phase 3 |
Epithelium-On Riboflavin;Epithelium-Off Riboflavin |
16 |
Corneal Sensitivity Cross-linking Keratoconus |
Completed |
NCT01743443
|
Phase 2, Phase 3 |
|
17 |
Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus |
Completed |
NCT00626717
|
Phase 2, Phase 3 |
|
18 |
Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus |
Completed |
NCT01672814
|
Phase 3 |
riboflavin ophthalmic solution |
19 |
Corneal Collagen Cross-linking for Progressive Keratoconus |
Completed |
NCT00647699
|
Phase 3 |
riboflavin ophthalmic solution |
20 |
Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia |
Completed |
NCT00567671
|
Phase 2, Phase 3 |
|
21 |
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus |
Completed |
NCT01643226
|
Phase 3 |
riboflavin solution;placebo solution |
22 |
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus |
Completed |
NCT01344187
|
Phase 3 |
riboflavin solution;placebo solution |
23 |
Deep Anterior Lamellar Keratoplasty (DALK) |
Completed |
NCT00887900
|
Phase 3 |
|
24 |
Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial |
Recruiting |
NCT01604135
|
Phase 3 |
|
25 |
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus |
Recruiting |
NCT03442751
|
Phase 3 |
Paracel 1;Paracel Placebo;Paracel 2 R0185 |
26 |
The Effects of Corneal Collagen Cross-linking |
Recruiting |
NCT01708538
|
Phase 3 |
CXL |
27 |
Accelerated Corneal Cross-linking With Different Riboflavin Solutions |
Recruiting |
NCT03187912
|
Phase 3 |
Riboflavin |
28 |
Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia |
Active, not recruiting |
NCT01464268
|
Phase 3 |
Riboflavin;Riboflavin |
29 |
Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia |
Active, not recruiting |
NCT03080077
|
Phase 3 |
Ricrolin+;Epi-Off |
30 |
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin |
Active, not recruiting |
NCT01152541
|
Phase 3 |
Riboflavin/Dextran;Hypotonic Riboflavin |
31 |
Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia |
Active, not recruiting |
NCT01112072
|
Phase 3 |
Riboflavin |
32 |
Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs |
Enrolling by invitation |
NCT01081561
|
Phase 2, Phase 3 |
Riboflavin |
33 |
Safety Study of the VEGA UV-A System to Treat Keratoconus |
Terminated |
NCT01190306
|
Phase 3 |
Riboflavin |
34 |
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus |
Terminated |
NCT01972854
|
Phase 3 |
riboflavin solution;placebo solution |
35 |
Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia |
Terminated |
NCT01398852
|
Phase 3 |
Riboflavin |
36 |
Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery |
Terminated |
NCT01459679
|
Phase 3 |
riboflavin ophthalmic solution |
37 |
Corneal Cross Linking and Topography Guided Excimer Laser Treatment |
Terminated |
NCT01682993
|
Phase 3 |
|
38 |
Corneal Crosslinking in Keratoconus and Corneal Ectasia |
Withdrawn |
NCT00679666
|
Phase 2, Phase 3 |
Riboflavin;Placebo |
39 |
Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus |
Unknown status |
NCT02507362
|
Phase 1, Phase 2 |
riboflavin 0.1% combined with dextran 20 % |
40 |
Myoring Versus Keraring Implantation for Keratoconus |
Unknown status |
NCT01869517
|
Phase 2 |
|
41 |
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking for Compassionate Treatment in Pediatric Patients With Progressive Keratoconus |
Unknown status |
NCT00925327
|
Phase 2 |
|
42 |
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia |
Unknown status |
NCT01325298
|
Phase 2 |
Riboflavin;Riboflavin |
43 |
Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL). |
Unknown status |
NCT02883478
|
Phase 1, Phase 2 |
riboflavin with hydroxypropyl methylcellulose |
44 |
Transepithelial Corneal Collagen Cross-linking (CXL) in Treatment of Keratoconus |
Completed |
NCT01181219
|
Phase 2 |
|
45 |
Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia |
Completed |
NCT01143389
|
Phase 2 |
Riboflavin |
46 |
Comparison of Partial Removal and Total Removal of the Corneal Epithelium on Keratoconus |
Completed |
NCT01809977
|
Phase 2 |
|
47 |
Lamellar Transplant With Lyophilized Corneas |
Completed |
NCT00409955
|
Phase 2 |
|
48 |
Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study |
Recruiting |
NCT01843101
|
Phase 2 |
|
49 |
Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study |
Recruiting |
NCT02834260
|
Phase 2 |
Dexamethasone implant OZURDEX |
50 |
COLLAGEN CROSS-LINKING WITH ULTRAVIOLET-A IN ASYMMETRIC CORNEAS |
Recruiting |
NCT03029104
|
Phase 2 |
|
Cochrane evidence based reviews: keratoconus
|